Applied Optoelectronics Stock (AAOI)

Upside – $RAPP +26% (Phase 2 RAP-219 trial met the primary and secondary endpoints in bipolar mania) – $MSCI +5.9% (Q3 earnings and revenue topped expectations) – $EFX +5.5% (sharply positive initial reaction to Q3 results released before the bell) – $HTZ +5.0% (Oro Mobility secured an $80 million strategic equity investment to accelerate its …

Upside – $TCRT +25.0% (extends its surge after closing a PAH-focused biotech acquisition and securing about $350M of financing) – $NCPL +19.0% (regains Nasdaq minimum-bid compliance) – $SITC +18.0% (declares a $3.00 special cash distribution after an asset sale and plans to delist from the NYSE) – $FFR +9.0% (launches the $2,490 FF Nova humanoid …

Upside – $VEEA +45.0% (regained full Nasdaq listing compliance following its reverse stock split) – $XRTX +21.0% (outlined planned FDA IND and Health Canada clinical-trial filings for XRx-026 in gout) – $SAIQ +19.5% (confirmed an October satellite launch advancing its post-quantum secure-communications roadmap) – $HUM +14.5% (2027 CMS Star Ratings exceeded its top-quartile revenue goal, …

Upside – $LPCN +40% (Health Canada approves TLANDO for testosterone replacement therapy) – $APUS +9.4% (extends a high-volume rally tied to the BlockAssure agreement to build and operate the AssureChain insurance network) – $PENG +4.3% (Q4 beat and FY27 sales and EPS outlook topped prior guidance and Street expectations on accelerating AI-infrastructure demand) – CNQ …